Evaluating Treatments for Amyotrophic Lateral Sclerosis
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to Cart failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from wishlist failed.
Please try again later
Adding to library failed
Please try again
Follow podcast failed
Please try again
Unfollow podcast failed
Please try again
Evaluating Treatments for Amyotrophic Lateral Sclerosis
-
Narrated by:
-
By:
About this listen
The HEALEY ALS platform is an innovative first attempt at platform trials in ALS, looking to slow ALS disease progression. Author Sabrina Paganoni, MD, PhD, of Massachusetts General Hospital and Harvard Medical School, discusses results of the first 4 drug regimens from this platform trial and how this study design makes efficient use of resources, with JAMA Deputy Editor Christopher Muth, MD.
Related Content:
- Platform Clinical Trials for the Efficient Evaluation of Multiple Treatments
- Pridopidine in Amyotrophic Lateral Sclerosis
- Platform Trials in ALS
- Verdiperstat in Amyotrophic Lateral Sclerosis
- Efficacy and Safety of Zilucoplan in Amyotrophic Lateral Sclerosis
- CNM-Au8 in Amyotrophic Lateral Sclerosis
adbl_web_global_use_to_activate_T1_webcro805_stickypopup
No reviews yet